Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date23 Jul 2018 |
100 Clinical Results associated with Hengshui Yiling Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Hengshui Yiling Pharmaceutical Co., Ltd.
100 Deals associated with Hengshui Yiling Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Hengshui Yiling Pharmaceutical Co., Ltd.